Electronic Fetal Heart Rate Monitoring: The Future

ISSN: 1875-6581 (Online)
ISSN: 1573-4048 (Print)


Volume 10, 2 Issues, 2014


Download PDF Flyer




Current Women's Health Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
John Yeh
Harvard Medical School
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, MA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Electronic Fetal Heart Rate Monitoring: The Future

Author(s): Taran Khangura and Edwin Chandraharan

Affiliation: Consultant Obstetrician and Gynaecologist, St. George’s Healthcare NHS Trust, Blackshaw Road, London SW 17 0RE, UK.

Abstract

Continuous electronic fetal heart rate monitoring (EFM) using a cardiotocograph (CTG) is associated with a high false positive rate of approximately 60%. Current scientific evidence does not support a significant reduction in perinatal mortality or cerebral palsy, except for a 50% reduction in neonatal convulsions. Recent scientific evidence has questioned the role of ‘peripheral’ tests of fetal wellbeing such as fetal scalp blood sampling (FBS), fetal scalp lactate and fetal pulse oximetry in reducing the false positive rate of CTG. Fetal ECG (ST-Analyzer or STAN) shows promise in reducing neonatal admissions and operative vaginal births. Computerized CTG analysis and Fetal Physiological Score (FPS) may help reduce errors associated with CTG interpretation.

Keywords: Fetal scalp blood sampling, fetal scalp lactate, ST-Analyzer (STAN), Fetal Physiological Score (FPS), computerised analysis.

Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 9
Issue Number: 3
First Page: 169
Last Page: 174
Page Count: 6
DOI: 10.2174/157340480903140131111807
Advertisement

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science